Alternatives in Cancer Therapy

Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy [Repost]

Sonia B. Jakowlew - Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
Published: 2008-02-28 | ISBN: 1588297152, 1617377368 | PDF | 786 pages | 61.7 MB

Chemoradiation in Cancer Therapy (repost)  eBooks & eLearning

Posted by libr at June 18, 2017
Chemoradiation in Cancer Therapy (repost)

Chemoradiation in Cancer Therapy (Cancer Drug Discovery and Development) by Hak Choy
English | December 4, 2002 | ISBN: 158829028X | Pages: 432 | PDF | 5 MB

Targeting Autophagy in Cancer Therapy  eBooks & eLearning

Posted by Jeembo at June 7, 2017
Targeting Autophagy in Cancer Therapy

Targeting Autophagy in Cancer Therapy by Jin-Ming Yang
English | 2016 | ISBN: 3319427385 | 141 Pages | PDF | 8.3 MB

This volume will detail the current state and perspectives of autophagy-based cancer therapy.

Targeting Autophagy in Cancer Therapy  eBooks & eLearning

Posted by interes at Feb. 8, 2017
Targeting Autophagy in Cancer Therapy

Targeting Autophagy in Cancer Therapy (Current Cancer Research) by Jin-Ming Yang
English | 2016 | ISBN: 3319427385 | 141 pages | PDF | 4 MB

Targeting Autophagy in Cancer Therapy  eBooks & eLearning

Posted by interes at Nov. 25, 2016
Targeting Autophagy in Cancer Therapy

Targeting Autophagy in Cancer Therapy (Current Cancer Research) by Jin-Ming Yang
English | 2016 | ISBN: 3319427385 | 141 pages | PDF | 4 MB

Proteasome Inhibitors in Cancer Therapy  eBooks & eLearning

Posted by MoneyRich at Nov. 17, 2016
Proteasome Inhibitors in Cancer Therapy

Proteasome Inhibitors in Cancer Therapy by Julian Adams
English | 25 May 2004 | ISBN: 1588292509 | 340 Pages | PDF | 7 MB

A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway.

Transforming Growth Factor-Beta in Cancer Therapy, Volume II (repost)  eBooks & eLearning

Posted by MoneyRich at Oct. 13, 2016
Transforming Growth Factor-Beta in Cancer Therapy, Volume II (repost)

Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy: v. 2 by Sonia B. Jakowlew
English | 25 Mar. 2008 | ISBN: 1588297152 | 786 Pages | PDF | 62 MB

Transforming Growth Factor- ß in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ß (TGF- ß) in cancer treatment and therapy. The second volume, Cancer Treatment in Therapy, is divided into three parts.

Tumor Targeting in Cancer Therapy  eBooks & eLearning

Posted by MoneyRich at Oct. 13, 2016
Tumor Targeting in Cancer Therapy

Tumor Targeting in Cancer Therapy by Michel Pagé
English | 19 May 2010 | ISBN: 161737251X | 476 Pages | PDF | 11 MB

In Tumor Targeting in Cancer Therapy, Dr. Michel Pagé and a panel of authoritative experts from the drug industry, clinics, and academia introduce the principles and techniques of tumor targeting and critically survey their applications from laboratory to bedside.

Matrix Metalloproteinase Inhibitors in Cancer Therapy  eBooks & eLearning

Posted by tanas.olesya at July 15, 2016
Matrix Metalloproteinase Inhibitors in Cancer Therapy

Matrix Metalloproteinase Inhibitors in Cancer Therapy by Neil J. Clendeninn
English | 17 Sept. 2000 | ISBN: 0896036685 | 280 Pages | PDF | 2 MB

Cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies.

Antifolate Drugs in Cancer Therapy  eBooks & eLearning

Posted by MoneyRich at Dec. 11, 2015
Antifolate Drugs in Cancer Therapy

Antifolate Drugs in Cancer Therapy by Ann Jackman
English | 24 Mar. 2013 | ISBN: 1475745214 | 472 Pages | PDF | 13 MB

Antifolates are an important class of anticancer drugs originally developed as anti leu­ kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar­ comas. 5-Fluorouracil and its prodrugs also target, in part, the folate-dependent enzyme, thymidylate synthase.